CT-planned internal mammary node radiotherapy in the DBCG-IMN study: Benefit versus potentially harmful effects

Acta Oncologica

Volumn 53, Issue 8, 2014, Pages 1027-1034

  Thorsen, Lise B J ^a   Thomsen, Mette S ^a   Berg, Martin ^b   Jensen, Ingelise ^c   Josipovic, Mirjana ^d   Overgaard, Marie ^a   Overgaard, Jens ^a   Skogholt, Peter ^b   Offersen, Birgitte V ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; EARLY CANCER; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY NODE RADIOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; NUMBERS NEEDED TO TREAT; ORGANS AT RISK; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RISK BENEFIT ANALYSIS; SIMULATION; ALGORITHM; BREAST NEOPLASMS; HEART; IMAGE GUIDED RADIOTHERAPY; LUNG; LYMPH NODE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; PROCEDURES; RADIATION RESPONSE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; CAUSE OF DEATH; TREATMENT PLANNING;

ALGORITHMS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HEART; HUMANS; LUNG; LYMPH NODES; LYMPHATIC IRRADIATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NEOPLASM, RESIDUAL; NUMBERS NEEDED TO TREAT; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED;

EID: 84906537585     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.925579     Document Type: Article

References (25)

1. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55
2. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8
3. Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: Analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008;107:379-87
4. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: Diagnosis and implications for patient management-A systematic review. J Clin Oncol 2008;26:4981-9
5. Overgaard M, Christensen JJ. Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience. Acta Oncol 2008;47:639-53
6. Thorsen LBJ, Berg M, Brodersen HJ, Danø H, Jensen I, Overgaard J, et al. Improved survival with internal mammary node irradiation: A prospective study on 3,072 breast cancer patients. Radiother Oncol 2014;111:67-8
7. Thorsen LB, Thomsen MS, Overgaard M, Overgaard J, Offersen BV. Quality assurance of conventional non-CTbased internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study. Acta Oncol 2013;52:1526-34
8. Darby SC, Ewertz M, McGale P, Bennet AM, Blom- Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-98
9. Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 2013;52:703-10
10. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. Br Med J 1999;319:1492-5
11. Nielsen HM, Christensen JJ, Aagaard T, Thingholm J, Overgaard M, Grau C. A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer. Clin Oncol (R Coll Radiol ) 2003;15:17-24
12. Knoos T, Wieslander E, Cozzi L, Brink C, Fogliata A, Albers D, et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 2006;51: 5785-807
13. Poortmans P, Kouloulias VE, Venselaar JL, Struikmans H, Davis JB, Huyskens D, et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary - medial supraclavicular irradiation in stage I-III breast cancer: The individual case review. Eur J Cancer 2003; 39:2035-42
14. Whelan T, Ackerman I, Chapman JW, Chua B, Nabid A, Vallis KA, et al. NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 2011;29(Suppl):abstr LBA1003
15. Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois JB, Datchary J, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 2013; 86:860-6
16. Budach W, Kammers K, Boelke E, Matuschek C. Adjuvant radiotherapy of regional lymph nodes in breast cancer-A meta-Analysis of randomized trials. Radiat Oncol 2013; 8:267
17. Taylor CW, Bronnum D, Darby SC, Gagliardi G, Hall P, Jensen MB, et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol 2011;100:176-83
18. Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and meta-Analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol 2013;112:1980-4
19. Brenner DJ, Shuryak I, Jozsef G, Dewyngaert KJ, Formenti SC. Risk and risk reduction of major coronary events associated with contemporary breast radiotherapy. JAMA Intern Med 2014;174:158-60
20. Grantzau T, Mellemkjaer L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol 2013;106:42-9
21. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer 2009;100:811-6
22. Johansen S, Fossa K, Nesvold IL, Malinen E, Fossa SD. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol 2014;53:521-9
23. Bartlett FR, Colgan RM, Carr K, Donovan EM, McNair HA, Locke I, et al. The UK HeartSpare Study: Randomised evaluation of voluntary deep-inspiratory breathhold in women undergoing breast radiotherapy. Radiother Oncol 2013;108:242-7
24. Varga Z, Cserhati A, Rarosi F, Boda K, Gulyas G, Egyud Z, et al. Individualized positioning for maximum heart protection during breast irradiation. Acta Oncol 2014;53:58-64
25. Mast ME, Van Kempen-Harteveld L, Heijenbrok MW, Kalidien Y, Rozema H, Jansen WP, et al. Left-sided breast cancer radiotherapy with and without breath-hold: Does IMRT reduce the cardiac dose even further?. Radiother Oncol 2013;108:248-53